Anyone placing a lyophilisate of a research peptide on the balance is not weighing the peptide alone. Every synthesised peptide is supplied as a salt: the peptide backbone is bound to a counterion left over from the synthesis and purification steps. Which counterion that is \u2014 usually trifluoroacetate (TFA) or acetate \u2014 has direct consequences for net weight, solubility and the reproducibility of an experiment. Yet this detail is often underexposed in laboratory documentation. This article explains where the difference comes from and why it is worth taking into account when setting up a protocol.<\/p>\n
In solid-phase synthesis, amino acids are coupled step by step to a solid support, after which the peptide is cleaved from that support with an acid. For most synthesis routes that acid is trifluoroacetic acid. Basic side chains in the peptide \u2014 of lysine, arginine or the N-terminus, for example \u2014 take on a positive charge in the process, and that charge is neutralised by a negatively charged counterion. After cleavage and purification that counterion remains bound to the peptide and is lyophilised along with it into the final powder. Hence virtually every commercial synthetic peptide is delivered as the TFA salt by default, unless explicitly ordered otherwise.<\/p>\n
TFA salt is the most common form because trifluoroacetic acid is used as an eluent in virtually every purification step in preparative HPLC. It is cheaper to produce and the conversion process introduces no extra processing steps that lower the yield. For many in vitro applications this is not a problem. For some cell culture or animal research, however, residual TFA can interfere: it can affect the pH of a solution and has been associated in certain models with deviant cellular responses at higher concentrations. That makes the choice of salt form relevant to the design of a research protocol, not merely to the accounting of molecular weight.<\/p>\n
For an acetate salt, the TFA counterion is exchanged for acetate via repeated dissolution in dilute acetic acid and renewed lyophilisation. Acetate is a lighter ion than TFA, which means an acetate salt powder of the same gross weight contains a higher percentage of actual peptide. The process requires extra processing steps and comes with a certain loss of yield, which explains why acetate salt is usually 20 to 30 per cent more expensive than the TFA variant. Researchers often choose it for sensitive test set-ups where a low residual counterion concentration is wanted, or when reproducibility between batches with a consistent purity definition matters more than cost.<\/p>\n
The counterion counts towards the gross weight of the lyophilisate, but not towards the biologically active peptide mass. Two vials with the same gross weight of powder can therefore contain a different actual peptide content, depending on the salt. A Certificate of Analysis ideally states not only the purity by HPLC, but also the net peptide content \u2014 the percentage of the weight that is actually peptide, after correcting for counterion, residual moisture and any non-peptide impurities. Anyone ignoring that figure and calculating from gross weight alone introduces a systematic deviation into every dilution series based on that weight.<\/p>\n
These questions are particularly relevant when results are compared between different suppliers or batches: a difference in salt form can explain part of an observed variation that would otherwise be wrongly attributed to the experiment itself.<\/p>\n
The choice between TFA and acetate salt is not a commercial detail, but a variable that weighs on the accuracy of every calculation based on the weight of a lyophilisate. Checking the salt form and the net peptide content on the CoA therefore belongs to protocol preparation just as naturally as checking purity itself.<\/p>\n
This information and the products of Dutch Peptide Labs are intended solely for laboratory and research purposes. Not intended for human or animal consumption, diagnostic use or therapeutic applications.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Anyone placing a lyophilisate of a research peptide on the balance is not weighing the peptide alone. Every synthesised peptide is supplied as a salt: the peptide backbone is bound to a counterion left over from the synthesis and purification steps. Which counterion that is \u2014 usually trifluoroacetate (TFA) or acetate \u2014 has direct consequences […]<\/p>\n","protected":false},"author":0,"featured_media":442,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1189","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-niet-gecategoriseerd"],"acf":[],"_links":{"self":[{"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/posts\/1189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/comments?post=1189"}],"version-history":[{"count":1,"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/posts\/1189\/revisions"}],"predecessor-version":[{"id":1224,"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/posts\/1189\/revisions\/1224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/media\/442"}],"wp:attachment":[{"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/media?parent=1189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/categories?post=1189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dutchpeptidelabs.nl\/en\/wp-json\/wp\/v2\/tags?post=1189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}